New immunofluorescence assays for detection of human herpesvirus 8-specific antibodies

被引:18
作者
Inoue, N
Mar, EC
Dollard, SC
Pau, CP
Zheng, Q
Pellett, PE
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA
关键词
D O I
10.1128/CDLI.7.3.427-435.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several assays have been developed for detection of immunoglobulin G antibodies to Human herpesvirus 8 (HHV-8), including immunofluorescence assays (IFAs) and enzyme-linked immunosorbent assays (ELISAs), However, the specificity and sensitivity of these assays are not completely defined due to the lack of a "gold standard." Although IFAs based on primary effusion lymphoma (PEL) cell lines are used widely, the assays can be confounded by nonspecific reactions against cellular components and potential cross-reaction with anti bodies against other herpesviruses. To provide more reliable IFAs, we established recombinant Semliki Forest viruses (rSFVs) expressing the HHV-8-specific proteins ORF73 and K8.1 and used BHK-21 cells infected with these rSFVs For IFA (ORF73-IFA and K8.1-IFA), Expression of the HHV-8-specific proteins at very high levels by the rSFV system allowed easy scoring for IFA and thereby increased specificity, The rSFV system also allowed detection of antibodies against glycosylation-dependent epitopes of K8.1. Titers measured by rSFV-based IFAs and PEL-based IFAs correlated well (correlation coefficients of >0.9), and concordances of seroreactivities between rSFV-based and PEL-based IFAs were >97% (kappa > 0.93). K8.1-IFA was more sensitive than either ORF73-IFA or peptide ELISAs. Using PEL-based lytic IFA as a reference assay, the sensitivity and specificity of K8.1-IFA were estimated to be 94 and 100%, respectively. HHV-8 prevalences determined by K8.1-IFA among the human immunodeficiency virus (HIV)-positive (HIV+) Kaposi's sarcoma (KS) patients, HIV+ KS- patients, and healthy controls were 100, 65, and 6.7%, respectively, which were consistent with prior reports. Therefore, our rSFV based IFAs may provide a specific and sensitive method for use in epidemiology studies. in addition, they will provide a basis for further development of diagnostic tests for HHV-8 infection.
引用
收藏
页码:427 / 435
页数:9
相关论文
共 39 条
[11]   Rapid, high level protein production using DNA-based semliki forest virus vectors [J].
DiCiommo, DP ;
Bremner, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18060-18066
[12]   Alphavirus-based expression vectors: Strategies and applications [J].
Frolov, I ;
Hoffman, TA ;
Pragai, BM ;
Dryga, SA ;
Huang, HV ;
Schlesinger, S ;
Rice, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11371-11377
[13]   KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma [J].
Gao, SJ ;
Kingsley, L ;
Li, M ;
Zheng, W ;
Parravicini, C ;
Ziegler, J ;
Newton, R ;
Rinaldo, CR ;
Saah, A ;
Phair, J ;
Detels, R ;
Chang, Y ;
Moore, PS .
NATURE MEDICINE, 1996, 2 (08) :925-928
[14]   Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma [J].
Gao, SJ ;
Kingsley, L ;
Hoover, DR ;
Spira, TJ ;
Rinaldo, CR ;
Saah, A ;
Phair, J ;
Detels, R ;
Parry, P ;
Chang, Y ;
Moore, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (04) :233-241
[15]   Recent advances in gene expression using alphavirus vectors [J].
Garoff, H ;
Li, KJ .
CURRENT OPINION IN BIOTECHNOLOGY, 1998, 9 (05) :464-469
[16]   Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS [J].
He, J ;
Bhat, G ;
Kankasa, C ;
Chintu, C ;
Mitchell, C ;
Duan, WJ ;
Wood, C .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1787-1790
[17]   Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus [J].
Kedes, DH ;
Lagunoff, M ;
Renne, R ;
Ganem, D .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2606-2610
[18]   The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission [J].
Kedes, DH ;
Operskalski, E ;
Busch, M ;
Kohn, R ;
Flood, J ;
Ganem, D .
NATURE MEDICINE, 1996, 2 (08) :918-924
[19]   Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8 [J].
Lang, D ;
Hinderer, W ;
Rothe, M ;
Sonneborn, HH ;
Neipel, F ;
Raab, M ;
Rabenau, H ;
Masquelier, B ;
Fleury, H .
VIROLOGY, 1999, 260 (01) :47-54
[20]   Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients [J].
Lennette, ET ;
Blackbourn, DJ ;
Levy, JA .
LANCET, 1996, 348 (9031) :858-861